Arrowhead Pharmaceuticals Inc. (ARWR) |
|
27.8 0.65 (2.39%)
|
07-15 16:00 |
|
Open: |
27.27 |
Pre. Close: |
27.15 |
|
High:
|
27.98 |
Low:
|
26.94 |
|
Volume:
|
710,599 |
Market Cap:
|
2636M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
28.006 - 28.114 |
28.114 - 28.237 |
|
Low:
|
26.651 - 26.765 |
26.765 - 26.896 |
|
Close:
|
27.583 - 27.77 |
27.77 - 27.985 |
|
Technical analysis |
as of: 2019-07-15 4:40:20 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 33.69  One year: 39.34 |
| Support: |
Support1: 26.89 Support2: 25.68 |
| Resistance: |
Resistance1: 28.84 Resistance2: 33.69 |
| Pivot: |
27.00  |
| Moving Average: |
MA(5): 26.92 MA(20): 27.12
MA(100): 21.56 MA(250): 17.57 |
| MACD: |
MACD(12,26): 0.59 Signal(9): 0.77 |
| Stochastic oscillator: |
%K(14,3): 44.30 %D(3): 34.42 |
| RSI: |
RSI(14): 60.81 |
| 52-week: |
High: 28.84 Low: 10.41 Change(%): 75.9 |
| Average Vol(K): |
3-Month: 211950 10-Days: 97606 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.ARWR has closed below upper band by 21.8%. Bollinger Bands are 26.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Mon, 01 Jul 2019 16:36:40 Z
Commit To Purchase Arrowhead Pharmaceuticals At $15, Earn 14% Using Options
Fri, 28 Jun 2019 20:27:43 Z
Health Care Sector Update for 06/28/2019: KRTX,UNH,ARWR,SRNE
Fri, 28 Jun 2019 18:27:43 Z
Health Care Sector Update for 06/28/2019: UNH,ARWR,SRNE
Fri, 14 Jun 2019 23:20:24 Z
7 Top-Rated Biotech Stocks to Invest In Today
Mon, 10 Jun 2019 16:09:41 Z
These 3 Biotech Stocks Doubled in the First Half of 2019
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
NA |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
94.81 |
| Shares Float (M) |
86.38 |
|
% Held by Insiders
|
8.81 |
|
% Held by Institutions
|
63.80 |
|
Shares Short (K)
|
19150 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
0.100 |
|
EPS Est. Current Year
|
-0.420 |
|
EPS Est. Next Year
|
-0.660 |
|
EPS Est. Next Quarter
|
-0.130 |
|
Forward EPS
|
-0.460 |
|
Book Value (p.s.)
|
2.120 |
|
PEG Ratio
|
5.05 |
|
Profit Margin
|
10.09 |
|
Operating Margin
|
6.19 |
|
Return on Assets (ttm)
|
1.6 |
|
Return on Equity (ttm)
|
6.1 |
|
Qtrly Rev. Growth
|
7306.0 |
|
Gross Profit (p.s.)
|
0.170 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
0.112 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
131.61 |
|
Levered Free Cash Flow (M)
|
94.05 |
Stock Valuations |
|
P/E
|
278.00 |
|
P/E Growth Ratio
|
0.02 |
|
P/BV
|
13.11 |
|
P/S
|
2510207488.00 |
|
P/CF
|
20.03 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
2011-11-17 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
